On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

CBD Popularity Growing with Expanded Wellness & Wellbeing Roles; Neutra Corp. (NTRR) Working to Strengthen Market Position

  • Entrance into the mainstream retail market and changing attitudes toward wellness are forecast to increase the popularity of CBD oil products in the years to come
  • Companies that establish their market position now will be primed to benefit from increased recognition in the future; Neutra Corp. is actively working to accomplish this goal
  • To achieve vertical integration, Neutra has finalized the acquisition of VIVIS, a renowned CBD brand, and is also looking into the acquisition of companies that have cultivation and production licenses

The popularity of CBD is growing constantly, with market forecasts indicating that the global CBD industry is likely to reach $22 billion by 2022 (http://nnw.fm/8x82D). One of the main reasons CBD’s popularity has exploded as of late is related to its multiple health benefits, according to clinical research. Various studies carried out over the years indicate that CBD has anti-inflammatory, anti-anxiety and cognitive-boosting qualities.

In addition, CBD has proven to be incredibly versatile. It’s being featured in a much bigger range of products than any other prominent wellness and health ingredient. CBD can be utilized in many different delivery systems. The ingestion delivery system is used to create foods, beverages, candy and snacks. The subdermal delivery system is used for topicals such as ointments, creams, skin care items and balms. From drinks to candy and even CBD-infused tampons, the range of possibilities seems to be limitless.

An additional shift in wellness trends is also contributing to the popularity of CBD applications. The market is seeing a change from excessive focus on workout routines over the past decade to a chill/slow down wellness mentality. This shift could soon contribute to the emergence of wellness centers that incorporate the use of CBD-based products in the overall relaxation experience (http://nnw.fm/dELm2).

These trends are expected to help the nutraceutical market grow exponentially in the years to come, reaching $578.23 billion by 2025. CBD oil is expected to have a significant impact on that expansion (http://nnw.fm/7jZ3h).

Companies like Neutra Corp. (OTCQB: NTRR) are uniquely positioned to take advantage of the industry’s potential and grab a sizable share of this fast-growing market. An early-stage research and development company focusing on cutting-edge technologies in the nutraceutical, food, drug and environmental purification sectors, Neutra Corp. is currently focused on the rapidly growing hemp sector. Committed to promoting vertical integration, Neutra is expanding its ability to cultivate, manufacture and distribute hemp-based CBD products.

The company is taking steps to expand its market reach via strategic acquisitions. On September 10, 2019, Neutra Corp. finalized its previously announced acquisition of VIVIS Corp., a key move that provides the company with invaluable retail market expansion opportunities. Co-founded by Neutra CEO Sydney Jim, VIVIS is a retail brand of CBD health and nutrition products. Its products satisfy the demand for high potency and high-quality hemp-based CBD oil goods. Third-party product certification differentiates the VIVIS range from other products, ensuring brand recognition.

The most efficient CBD ingestion method is a soft gel, which is the reason why VIVIS launched a soft gel supplement first (http://nnw.fm/q19AG). This is the easiest way to take an entire dosage of CBD at once, versus spreading it out over time by drinking a 20-ounce beverage or consuming a plate of food.

Thus far in 2019, Neutra has also pursued the acquisition of various companies that hold licenses for the cultivation and processing of hemp. Notably, Neutra entered into a letter of intent to acquire J3 Holdings – a renowned and well-established hemp cultivator. J3 Holdings has land, a warehouse and a cultivation license that could prove to be an invaluable addition to the Neutra Corp. portfolio.

For more information, visit the company’s website at www.NeutraInc.com

NOTE TO INVESTORS: The latest news and updates relating to NTRR are available in the company’s newsroom at http://nnw.fm/NTRR

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.networknewswire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Archives

Select A Month

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217